Value Bridge — METHODIST MANSFIELD MEDICAL CENTER
Current $28M → Target $35M (+$7.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$27.8M
Current EBITDA
$35.5M
Target EBITDA
+$7.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.7M
Payer Mix Optimization
$4.2M
Cost to Collect Reduction
$1.4M
Clean Claim Improvement
$1.0M
Volume & Rate Growth
$6.9M
What This Means
The 7-lever model projects a 28% EBITDA uplift from $28M to $35M. The highest-impact lever is Volume & Rate Growth at $2.8M probability-weighted.
IC talking point: "We see $8M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $84M in equity value creation."